Computationally designed high specificity inhibitors delineate the roles of BCL2 family proteins in cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Computationally designed high specificity inhibitors delineate the roles of BCL2 family proteins in cancer
Authors
Keywords
-
Journal
eLife
Volume 5, Issue -, Pages -
Publisher
eLife Sciences Organisation, Ltd.
Online
2016-11-02
DOI
10.7554/elife.20352
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of the pro-survival molecule Bfl-1 in melanoma
- (2015) C.K. Hind et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Kojak: Efficient Analysis of Chemically Cross-Linked Protein Complexes
- (2015) Michael R. Hoopmann et al. JOURNAL OF PROTEOME RESEARCH
- Genomic analysis and selective small molecule inhibition identifies BCL-XL as a critical survival factor in a subset of colorectal cancer
- (2015) Haichao Zhang et al. Molecular Cancer
- Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy
- (2015) Joel D. Leverson et al. Science Translational Medicine
- Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)
- (2015) J D Leverson et al. Cell Death & Disease
- The molecular architecture of the Dam1 kinetochore complex is defined by cross-linking based structural modelling
- (2015) Alex Zelter et al. Nature Communications
- An Inducible Lentiviral Guide RNA Platform Enables the Identification of Tumor-Essential Genes and Tumor-Promoting Mutations In Vivo
- (2015) Brandon J. Aubrey et al. Cell Reports
- Designed BH3 Peptides with High Affinity and Specificity for Targeting Mcl-1 in Cells
- (2014) Glenna Wink Foight et al. ACS Chemical Biology
- A Computationally Designed Inhibitor of an Epstein-Barr Viral Bcl-2 Protein Induces Apoptosis in Infected Cells
- (2014) Erik Procko et al. CELL
- Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in p53
- (2014) G. L. Kelly et al. GENES & DEVELOPMENT
- Peptide Ligands for Pro-survival Protein Bfl-1 from Computationally Guided Library Screening
- (2013) Sanjib Dutta et al. ACS Chemical Biology
- Computational Design of a Protein-Based Enzyme Inhibitor
- (2013) Erik Procko et al. JOURNAL OF MOLECULAR BIOLOGY
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- (2013) Andrew J Souers et al. NATURE MEDICINE
- In Silico and in Vitro Elucidation of BH3 Binding Specificity toward Bcl-2
- (2012) Nir London et al. BIOCHEMISTRY
- Nuclear EGFRvIII-STAT5b complex contributes to glioblastoma cell survival by direct activation of the Bcl-XL promoter
- (2012) Khatri Latha et al. INTERNATIONAL JOURNAL OF CANCER
- Predictive Bcl-2 Family Binding Models Rooted in Experiment or Structure
- (2012) Joe DeBartolo et al. JOURNAL OF MOLECULAR BIOLOGY
- Overview of theCCP4 suite and current developments
- (2011) Martyn D. Winn et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Enrich: software for analysis of protein function by enrichment and depletion of variants
- (2011) Douglas M. Fowler et al. BIOINFORMATICS
- The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy
- (2011) P N Kelly et al. CELL DEATH AND DIFFERENTIATION
- Transient binding of an activator BH3 domain to the Bak BH3-binding groove initiates Bak oligomerization
- (2011) Haiming Dai et al. JOURNAL OF CELL BIOLOGY
- Substantial Susceptibility of Chronic Lymphocytic Leukemia to BCL2 Inhibition: Results of a Phase I Study of Navitoclax in Patients With Relapsed or Refractory Disease
- (2011) Andrew W. Roberts et al. JOURNAL OF CLINICAL ONCOLOGY
- A Unified Model of Mammalian BCL-2 Protein Family Interactions at the Mitochondria
- (2011) Fabien Llambi et al. MOLECULAR CELL
- RosettaScripts: A Scripting Language Interface to the Rosetta Macromolecular Modeling Suite
- (2011) Sarel J. Fleishman et al. PLoS One
- Computational Design of Proteins Targeting the Conserved Stem Region of Influenza Hemagglutinin
- (2011) S. J. Fleishman et al. SCIENCE
- BH3-only proteins: Orchestrators of apoptosis
- (2010) Aisha Shamas-Din et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Evidence that inhibition of BAX activation by BCL-2 involves its tight and preferential interaction with the BH3 domain of BAX
- (2010) Bonsu Ku et al. CELL RESEARCH
- Determinants of BH3 Binding Specificity for Mcl-1 versus Bcl-xL
- (2010) Sanjib Dutta et al. JOURNAL OF MOLECULAR BIOLOGY
- Computational Design of Epitope-Scaffolds Allows Induction of Antibodies Specific for a Poorly Immunogenic HIV Vaccine Epitope
- (2010) Bruno E. Correia et al. STRUCTURE
- Phosphorylation of Puma modulates its apoptotic function by regulating protein stability
- (2010) M Fricker et al. Cell Death & Disease
- A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy
- (2010) W J Placzek et al. Cell Death & Disease
- Stepwise Activation of BAX and BAK by tBID, BIM, and PUMA Initiates Mitochondrial Apoptosis
- (2009) Hyungjin Kim et al. MOLECULAR CELL
- The BH4 domain of Bcl-2 inhibits ER calcium release and apoptosis by binding the regulatory and coupling domain of the IP3 receptor
- (2009) Y.-P. Rong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
- (2008) C. Tse et al. CANCER RESEARCH
- A novel BH3 ligand that selectively targets Mcl-1 reveals that apoptosis can proceed without Mcl-1 degradation
- (2008) Erinna F. Lee et al. JOURNAL OF CELL BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started